BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 18354112)

  • 1. Teriparatide or alendronate in glucocorticoid-induced osteoporosis.
    Rossi CM; Di Comite G
    N Engl J Med; 2008 Mar; 358(12):1302; author reply 1303-4. PubMed ID: 18354112
    [No Abstract]   [Full Text] [Related]  

  • 2. Teriparatide or alendronate in glucocorticoid-induced osteoporosis.
    Babb RR
    N Engl J Med; 2008 Mar; 358(12):1302-3; author reply 1303-4. PubMed ID: 18357641
    [No Abstract]   [Full Text] [Related]  

  • 3. Anabolic therapy in glucocorticoid-induced osteoporosis.
    Sambrook PN
    N Engl J Med; 2007 Nov; 357(20):2084-6. PubMed ID: 18003966
    [No Abstract]   [Full Text] [Related]  

  • 4. Baseline glucocorticoid dose and bone mineral density response with teriparatide or alendronate therapy in patients with glucocorticoid-induced osteoporosis.
    Devogelaer JP; Adler RA; Recknor C; See K; Warner MR; Wong M; Krohn K
    J Rheumatol; 2010 Jan; 37(1):141-8. PubMed ID: 19918047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone formation markers in patients with glucocorticoid-induced osteoporosis treated with teriparatide or alendronate.
    Eastell R; Chen P; Saag KG; Burshell AL; Wong M; Warner MR; Krege JH
    Bone; 2010 Apr; 46(4):929-34. PubMed ID: 20060078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of alendronate on glucocorticoid-induced osteoporosis].
    Zou X; Li Q; Shi C
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Jun; 34(6):563-5. PubMed ID: 19587443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy of teriparatide in treatment of glucocorticoid-induced osteoporosis].
    Soen S
    Clin Calcium; 2012 Mar; 22(3):315-20. PubMed ID: 22370297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Teriparatide or alendronate in glucocorticoid-induced osteoporosis.
    Saag KG; Shane E; Boonen S; Marín F; Donley DW; Taylor KA; Dalsky GP; Marcus R
    N Engl J Med; 2007 Nov; 357(20):2028-39. PubMed ID: 18003959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Active comparator trial of teriparatide vs alendronate for treating glucocorticoid-induced osteoporosis: results from the Hispanic and non-Hispanic cohorts.
    Losada BR; Zanchetta JR; Zerbini C; Molina JF; De la Peña P; Liu CC; Smith RB; Nino AJ; Krohn K; Warner MR
    J Clin Densitom; 2009; 12(1):63-70. PubMed ID: 19028124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trabecular Bone Score in Patients With Chronic Glucocorticoid Therapy-Induced Osteoporosis Treated With Alendronate or Teriparatide.
    Saag KG; Agnusdei D; Hans D; Kohlmeier LA; Krohn KD; Leib ES; MacLaughlin EJ; Alam J; Simonelli C; Taylor KA; Marcus R
    Arthritis Rheumatol; 2016 Sep; 68(9):2122-8. PubMed ID: 27111239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alendronate or alfacalcidol in glucocorticoid-induced osteoporosis.
    Kishimoto M; Oishi A; Motojima S
    N Engl J Med; 2006 Nov; 355(20):2156; author reply 2157. PubMed ID: 17108350
    [No Abstract]   [Full Text] [Related]  

  • 12. [New therapeutic approach in glucocorticoid-induce osteoporosis].
    Jakob F; Nitschmann S
    Internist (Berl); 2008 Dec; 49(12):1524-5. PubMed ID: 19018505
    [No Abstract]   [Full Text] [Related]  

  • 13. [Secondary osteoporosis UPDATE. Clinical significance of glucocorticoid-induced osteoporosis].
    Suzuki Y; Sato S
    Clin Calcium; 2010 May; 20(5):645-53. PubMed ID: 20445275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is the current anti-osteoporotic therapy paradigm good enough?
    Fisher AA; Davis MW
    J Am Geriatr Soc; 2006 Dec; 54(12):1960-1, author reply 1961-3. PubMed ID: 17198519
    [No Abstract]   [Full Text] [Related]  

  • 15. [Diagnosis, clinical feature and treatment of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis].
    Nakayama H
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():499-503. PubMed ID: 18161156
    [No Abstract]   [Full Text] [Related]  

  • 16. Alendronate or alfacalcidol in glucocorticoid-induced osteoporosis.
    Minisola S; Scillitani A; Romagnoli E
    N Engl J Med; 2006 Nov; 355(20):2156-7; author reply 2157. PubMed ID: 17120352
    [No Abstract]   [Full Text] [Related]  

  • 17. Anabolic therapies for osteoporosis.
    Uihlein AV; Leder BZ
    Endocrinol Metab Clin North Am; 2012 Sep; 41(3):507-25. PubMed ID: 22877427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Teriparatide or alendronate in glucocorticoid-induced osteoporosis.
    Nori US; Agarwal AK; Rovin BH
    N Engl J Med; 2008 Mar; 358(12):1302-3; author reply 1303-4. PubMed ID: 18357640
    [No Abstract]   [Full Text] [Related]  

  • 19. Advances in treatment of glucocorticoid-induced osteoporosis.
    Hsu E; Nanes M
    Curr Opin Endocrinol Diabetes Obes; 2017 Dec; 24(6):411-417. PubMed ID: 28857847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucocorticoid-induced osteoporosis: a review on pathophysiology and treatment options.
    De Nijs RN
    Minerva Med; 2008 Feb; 99(1):23-43. PubMed ID: 18299694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.